Keywords

• 52232-67-4
• Teriparatide acetate
• pTH (1-34) (human) acetate salt API peptide 5mg 10mg 15mg vials raw powder

Quick Details

• ProName: Teriparatide acetate CAS 52232-67-4
• CasNo: 52232-67-4
• Molecular Formula: C153H225N43O49S
• Appearance: powder
• Application: Use of pTH (1-34) (human) acetate salt...
• DeliveryTime: 3-7days
• PackAge: Fresco Bag/carton/box
• Port: shenzhen/shanghai/tianjin/dongguan
• ProductionCapacity: 10 Metric Ton/Month
• Purity: 98%
• Storage: dry
• Transportation: 1. The package can be delivered withi...
• LimitNum: 5 Milligram
• Moisture Content: <0.01%
• Impurity: <0.01%
• ProName: Teriparatide acetate
• DeliveryTime: 1-3 working days after confirming
• Transportation: by courier,by air or by sea.
• Storage: Seal and store away from light
• Payment Terms: T/T
• MOQ: 5mg
• ProductionCapacity: 5000 Kilogram/Month
• cas: 52232-67-4
• Appearance: White powder
• name: pTH (1-34) (human) acetate salt

Superiority

In Osteoporosis:
Teriparatide is a recombinant product representing the first 34 amino acids in human parathyroid hormone. Teriparatide increases bone formation, the bone remodeling rate, and osteoblast number and activity. Both bone mass and architecture are improved.
Teriparatide is FDA approved for postmenopausal women and men who are at high risk for fracture. Candidates for therapy include patients with a history of osteoporotic fracture, multiple risk factors for fracture, very low bone density (e.g., T-score <–3.5), or those who have failed or are intolerant of previous bisphosphonate therapy.
The drug reduces fracture risk in postmenopausal women, but no fracture data are available in men. Lumbar spine BMD increases are higher than with any other osteoporosis therapy. Although wrist BMD is decreased, wrist fractures are not increased.

Discontinuation of therapy results in a decrease in BMD, but some antifracture efficacy appears to be maintained. Sequential therapy with teriparatide followed by an antiresorptive agent (e.g., bisphosphonate) should be considered to maintain BMD gains.
The dose is 20 mcg administered subcutaneously in the thigh or abdominal area (see Table 3-4). The initial dose should be given with the patient either lying or sitting, in case orthostatic hypotension occurs. Each prefilled 3-mL pen device delivers a 20-mcg dose each day for up to 28 days; the pen device should be kept refrigerated.
Transient hypercalcemia rarely occurs. A trough serum calcium concentration is recommended 1 month after initiation of therapy.
Teriparatide is contraindicated in patients at baseline increased risk for osteosarcoma (e.g., Paget’s bone disease, unexplained alkaline phosphatase elevations, pediatric patients, young adults with open epiphyses, or patients with prior radiation therapy involving the skeleton).

Details

Packaging & Shipping

Company Profile

Shanghai Yimingsheng Electronic Technology Co., Ltd. is a high-tech enterprise focusing on the production of peptide products. It is an integration of industry and trade, with a wide range of products and a wide range of services. The following will introduce our company from three aspects:
1.Yimingsheng is an integration of industry and trade. The company has focused on making peptide products for nearly 20 years. It insists on being customer-centered and creates value for customers through efficient team work and high-quality products and services. The company has multiple departments and a clear division of labor. , and has its own factory. The company has a strong scientific research and technical team that can provide customers with high-quality products and all-round services. The company has always been determined to make every product carefully and serve every customer well. Our core values ??are empowerment, professionalism, diligence, conscientiousness, and gratitude.
2. Business scope and brand strength:
The company’s business covers many countries, mainly exporting to more than 30 countries including the United States, Europe, Southeast Asia, Australia, the Middle East and South Africa. Serving a wide range of people. We have our own independent brand, our product technology has passed multiple certifications, and our corporate credibility is excellent. And we can accept customized products to meet customers’ various product needs. The strength of the company’s brand comes from the company’s steady progress, and even more from the recognition of customers. The company adheres to the principle of considering problems from the customer’s perspective, and its dedicated service has been satisfied and recognized by new and old customers.
3. After-sales service and corporate vision:
We have our own overseas warehouses in multiple countries. Regarding delivery issues, we can deliver quickly, and we have our own special channels to 100% ensure that every customer receives our products. We will meet the needs of each of our customers with first-class products and quality services. Our goal is to become the leading global peptide supply expert in China.

Our advantages